Literature DB >> 35837199

Unexpected plasmablastic lymphoma in a young adult with unknown HIV infection: case report.

Austin L Gray1, Daniel Ding1, Ziphezinhle Ncube2, Kaushik Mukherjee2, Justin Kerstetter1, Yan Liu1, Jun Wang1.   

Abstract

Background: Plasmablastic lymphoma (PBL) is a rare, highly aggressive lymphoma of plasma cell differentiation. It commonly presents as an Epstein-Barr virus (EBV)+ oral lesion in an immunodeficient patient, predominately human immunodeficiency virus (HIV)+ patients. These aggressive lesions often demonstrate an immunoblastic or plasmablastic morphology with a typical immunohistochemical profile. The current case is unique due to the location at presentation, immunohistochemical features, and unknown presence of HIV infection in a young adult male. Case Presentation: We present an unexpected case of PBL found in a rare extra-oral location in a young adult male with undiagnosed HIV infection presenting as a perianal hemorrhoid mass/abscess. Swift treatment for HIV and the PBL resulted in complete remission and markedly improved CD4 counts. Conclusions: This case highlights the importance of testing for HIV along with acquiring a thorough social/clinical history when a PBL is encountered. Although the overall prognosis of PBL is dismal with a median survival of about 6-11 months, a timely accurate diagnosis and prompt chemotherapy with an appropriate regimen along with antiretroviral therapy (ART) may still achieve a successful outcome with a relatively reasonable long-term remission like in our reported case. 2022 Journal of Gastrointestinal Oncology. All rights reserved.

Entities:  

Keywords:  Epstein-Barr virus (EBV); Plasmablastic lymphoma (PBL); case report; human immunodeficiency virus (HIV)

Year:  2022        PMID: 35837199      PMCID: PMC9274066          DOI: 10.21037/jgo-21-779

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  6 in total

1.  Plasmablastic lymphoma versus plasmablastic myeloma: an ongoing diagnostic dilemma.

Authors:  Janice S Ahn; Ryan Okal; Jeffrey A Vos; Matthew Smolkin; Abraham S Kanate; Flavia G Rosado
Journal:  J Clin Pathol       Date:  2017-03-01       Impact factor: 3.411

Review 2.  The biology and treatment of plasmablastic lymphoma.

Authors:  Jorge J Castillo; Michele Bibas; Roberto N Miranda
Journal:  Blood       Date:  2015-01-30       Impact factor: 22.113

3.  Clinical and pathological aspects of human immunodeficiency virus-associated plasmablastic lymphoma: analysis of 24 cases.

Authors:  Yusuke Koizumi; Tomoko Uehira; Yasunori Ota; Yoshihiko Ogawa; Keishiro Yajima; Junko Tanuma; Mihoko Yotsumoto; Shotaro Hagiwara; Satoshi Ikegaya; Dai Watanabe; Hitoshi Minamiguchi; Keiko Hodohara; Kenta Murotani; Hiroshige Mikamo; Hideho Wada; Atsushi Ajisawa; Takuma Shirasaka; Hirokazu Nagai; Yoshinori Kodama; Tsunekazu Hishima; Makoto Mochizuki; Harutaka Katano; Seiji Okada
Journal:  Int J Hematol       Date:  2016-09-07       Impact factor: 2.490

4.  Plasmoblastic lymphoma as cause of perianal fistula: a case report and literature review.

Authors:  Firoozeh Isfahani; Surabhi Amar; Harikrishna Dave; Daniel Gridley
Journal:  J Int Assoc Provid AIDS Care       Date:  2014-10-15

Review 5.  Plasmablastic Lymphoma: A Review of Clinicopathologic Features and Differential Diagnosis.

Authors:  Charles M Harmon; Lauren B Smith
Journal:  Arch Pathol Lab Med       Date:  2016-10       Impact factor: 5.534

6.  HIV-negative plasmablastic lymphoma: report of 8 cases and a comprehensive review of 394 published cases.

Authors:  Ya-Jun Li; Ji-Wei Li; Kai-Lin Chen; Jin Li; Mei-Zuo Zhong; Xian-Ling Liu; Ping-Yong Yi; Hui Zhou
Journal:  Blood Res       Date:  2020-03-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.